X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
cardiac & cardiovascular systems (21) 21
humans (16) 16
cholesterol (13) 13
male (13) 13
female (11) 11
heart failure (11) 11
cardiovascular (10) 10
abridged index medicus (9) 9
drug therapy (9) 9
treatment outcome (9) 9
efficacy (8) 8
internal medicine (8) 8
low density lipoprotein (8) 8
monoclonal antibodies (8) 8
clinical trials (7) 7
hypercholesterolemia (7) 7
low density lipoproteins (7) 7
middle aged (7) 7
peripheral vascular disease (7) 7
statins (7) 7
analysis (6) 6
antibodies, monoclonal - administration & dosage (6) 6
double-blind method (6) 6
drug therapy, combination (6) 6
research (6) 6
adult (5) 5
aged (5) 5
animals (5) 5
cardiovascular diseases (5) 5
care and treatment (5) 5
myosin (5) 5
risk factors (5) 5
statin therapy (5) 5
amg 145 (4) 4
antibodies, monoclonal - adverse effects (4) 4
antibodies, monoclonal - therapeutic use (4) 4
cardiac patients (4) 4
cardiovascular disease (4) 4
cholesterol, ldl - blood (4) 4
cytochrome-c (4) 4
human necessities (4) 4
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (4) 4
hygiene (4) 4
ldl (4) 4
lipids (4) 4
medical or veterinary science (4) 4
medical research (4) 4
medicine, experimental (4) 4
medicine, general & internal (4) 4
metaanalysis (4) 4
mice (4) 4
monoclonal-antibody (4) 4
muscle proteins (4) 4
peptides (4) 4
preparations for medical, dental, or toilet purposes (4) 4
proprotein convertase 9 (4) 4
proprotein convertase 9 - antagonists & inhibitors (4) 4
safety (4) 4
usage (4) 4
activation (3) 3
anticholesteremic agents - adverse effects (3) 3
anticholesteremic agents - therapeutic use (3) 3
apoptosis (3) 3
apoptotic protease-activating factor 1 (3) 3
bcl-2 (3) 3
cardiovascular agents (3) 3
cardiovascular diseases - blood (3) 3
cardiovascular diseases - drug therapy (3) 3
cardiovascular diseases - epidemiology (3) 3
cardiovascular system & cardiology (3) 3
caspase (3) 3
caspases - metabolism (3) 3
chemistry (3) 3
cholesterol, ldl (3) 3
clinical trials as topic (3) 3
cytochrome c group - metabolism (3) 3
density-lipoprotein cholesterol (3) 3
disease (3) 3
dose-response relationship, drug (3) 3
double-blind (3) 3
drug dosages (3) 3
endocrinology & metabolism (3) 3
enzyme activation (3) 3
genetic aspects (3) 3
homozygote (3) 3
hyperlipoproteinemia type ii - blood (3) 3
hyperlipoproteinemia type ii - drug therapy (3) 3
hyperlipoproteinemia type ii - genetics (3) 3
injections, subcutaneous (3) 3
ldl-c (3) 3
metallurgy (3) 3
mice, knockout (3) 3
organic chemistry (3) 3
outcomes (3) 3
pathways (3) 3
patients (3) 3
pcsk9 (3) 3
placebo-controlled trial (3) 3
prevention (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9965, pp. 341 - 350
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 173, pp. 94 - 101
Background Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events. Low-density lipoprotein... 
Cardiovascular | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EVOLOCUMAB AMG 145 | STATIN THERAPY | LDL-C | LOW-DENSITY-LIPOPROTEIN | PRIMARY-PREVENTION TRIAL | MONOCLONAL-ANTIBODY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Incidence | Dose-Response Relationship, Drug | Cholesterol, VLDL - drug effects | Injections, Subcutaneous | Lipoproteins, LDL - drug effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Serine Endopeptidases | Drug Therapy, Combination | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Treatment Outcome | Cholesterol, VLDL - blood | Australia - epidemiology | Antibodies, Monoclonal - administration & dosage | Norway - epidemiology | United Kingdom - epidemiology | Lipoproteins, LDL - blood | Proprotein Convertase 9 | Monoclonal antibodies | Blood circulation disorders | Low density lipoproteins | Risk factors | Vascular diseases | Clinical trials | Cardiovascular disease | Lipids | Cardiovascular diseases | Low density lipoprotein | Statins | Morbidity | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 12/2016, Volume 388, Issue 10062, pp. 2895 - 2903
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 7, pp. 633 - 643
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
Journal Article